Clinical Trial Update: Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the combination of capecitabine and oxaliplatin in patients with locally advanced, unresectable, or metastatic gastric cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Gastric Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-07-16